Document Detail

Statin or fibrate chronic treatment modifies the proteomic profile of rat skeletal muscle.
MedLine Citation:
PMID:  21300028     Owner:  NLM     Status:  Publisher    
Statins and fibrates can cause myopathy. To further understand the causes of the damage we performed a proteome analysis in fast-twitch skeletal muscle of rats chronically treated with different hypolipidemic drugs. The proteomic maps were obtained from extensor digitorum longus (EDL) muscles of rats treated for 2-months with 10mg/kg atorvastatin, 20mg/kg fluvastatin, 60mg/kg fenofibrate and control rats. The proteins differentially expressed were identified by mass spectrometry and further analysed by immunoblot analysis. We found a significant modification in 40 out of 417 total spots analysed in atorvastatin treated rats, 15 out of 436 total spots in fluvastatin treated rats and 21 out of 439 total spots in fenofibrate treated rats in comparison to controls. All treatments induced a general tendency to a down-regulation of protein expression; in particular, atorvastatin affected the protein pattern more extensively with respect to the other treatments. Energy production systems, both oxidative and glycolytic enzymes and creatine kinase, were down-regulated following atorvastatin administration, whereas fenofibrate determined mostly alterations in glycolytic enzymes and creatine kinase, oxidative enzymes being relatively spared. Additionally, all treatments resulted in some modifications of proteins involved in cellular defenses against oxidative stress, such as heat shock proteins, and of myofibrillar proteins. These results were confirmed by immunoblot analysis. In conclusions, the proteomic analysis showed that either statin or fibrate administration can modify the expression of proteins essential for skeletal muscle function suggesting potential mechanisms for statin myopathy.
Giulia Maria Camerino; Maria Antonietta Pellegrino; Lorenza Brocca; Claudio Digennaro; Diana Conte Camerino; Sabata Pierno; Roberto Bottinelli
Related Documents :
234828 - Disposition of cyproheptadine in rats, mice, and humans and identification of a stable ...
2681678 - Differentiation of kinin fractions in ureter urine and bladder urine of normal and kini...
16258078 - In vivo metabolism of [14c]ruboxistaurin in dogs, mice, and rats following oral adminis...
23194618 - Hypotensive effects of some extracts of the leaves of musanga cecropioides (cecropiacea...
2270368 - Pathophysiology of experimental nephrotic syndrome induced by puromicyn aminonucleoside...
17369198 - Sensitivity of fetal rat testicular steroidogenesis to maternal prochloraz exposure and...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-2-4
Journal Detail:
Title:  Biochemical pharmacology     Volume:  -     ISSN:  1873-2968     ISO Abbreviation:  -     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-2-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0101032     Medline TA:  Biochem Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011. Published by Elsevier Inc.
Department of Pharmacobiology, Section of Pharmacology, Faculty of Pharmacy, University of Bari "Aldo Moro", Via Orabona 4, 70124, Bari, ITALY.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Friendly, and not so friendly, roles of Rac1 in islet ?-cell function: lessons learnt from pharmacol...
Next Document:  A comprehensive understanding of thioTEPA metabolism in the mouse using UPLC-ESI-QTOFMS-based metabo...